Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455985 | SCV000539904 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001512625 | SCV001720072 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001782919 | SCV002026790 | benign | Respiratory papillomatosis, juvenile recurrent, congenital | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001782918 | SCV002026791 | benign | Autoinflammation with arthritis and dyskeratosis | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001782917 | SCV002026792 | benign | Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000455985 | SCV004122984 | benign | not specified | 2023-11-14 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 64% of patients studied by a panel of primary immunodeficiencies. Number of patients: 61. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001512625 | SCV005254855 | benign | not provided | criteria provided, single submitter | not provided |